The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled, “Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further states that this market size was USD 2.02 billion in 2019 and is projected to reach USD 2.93 billion by 2027, thereby exhibiting a CAGR of 4.8% during the forecast period.
To Understand Cancer Cachexia Market Key Trends, Download Sample Report:
The emergence of the COVID-19 pandemic has brought the entire world to a standstill. The governments of several countries have implemented lockdown measures to prevent the spread of this deadly infection. Such initiatives have caused disruptions in the production and supply chain. But, with time and perseverance, we will be able to battle this severe phase and come back to normalcy. Our authentic reports would help you to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.
Drivers & Restraints-
Rising Incidence of Cancer Cachexia to Skyrocket Demand
The rising prevalence of cachexia, as well as cancer is further creating a huge patient pool requiring treatment for the same. The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD), a non-profit organization, mentioned in a report that in the developing nations, approximately 0.5-1.0% of the total population suffer from cancer cachexia. Besides, the World Health Organization (WHO) declared that around 18.1 million new cases of cancer were reported in 2018 globally. These researches prove that the demand for cancer cachexia therapeutics is set to surge in the near future. However, the strict government rules and regulations regarding the clinical trials of new candidates may hamper the cancer cachexia market growth in the coming years.
Quick Buy – Cancer Cachexia Market Research Report:
Fortune Business Insights™ presents a list of all the providers of cancer cachexia therapeutics operating in the global market. They are as follows:
Bristol-Myers Squibb Company, New York, U.S.
ANI Pharmaceuticals, Inc., Baudette, U.S.
Merck & Co., Inc., Kenilworth, U.S.
Hikma Pharmaceuticals PLC, London, U.K.
Mylan N.V., Pennsylvania, U.S.
AbbVie, Inc., North Chicago, U.S.
Pfizer Inc., New York, U.S.
Teva Pharmaceutical Industries Ltd., Petach-Tikva, Israel
North America to Lead Backed by Presence of Favorable Reimbursement Policies
Geographically, in 2019, North America procured USD 0.80 billion in terms of revenue. The region is likely to lead the market throughout the forecast period. This growth is attributable to the increasing awareness programs amongst the masses about the benefits of supportive care for cancer. Apart from this, the presence of favorable reimbursement policies in the developed countries, such as Canada and the U.S. would contribute to the growth of the market in this region. Europe is expected to exhibit a considerable CAGR in the coming years owing to the high demand for therapeutics for the treatment of cancer cachexia. Asia Pacific, on the other hand, is set to grow significantly fueled by the increasing investments by the prominent companies present in the region in research and development activities.
This Report Answers the Following Questions:
What are the market drivers, dynamics, and hindrances?
How will the COVID-19 pandemic affect the market in the coming years?
Which strategies are presently adopted by the companies to intensify competition?
What are the estimated, current, and historical sizes of the market?
Which region is set to dominate the market in terms of revenue?
Have Any Query? Ask Our Experts:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Linkedin | Twitter | BLogs